We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTEC
2426
DELISTED
NEOSE TECHNOLOGIES INC
NTEC
$0 ﹤0.01%
+200
New
IAR
2427
DELISTED
IDEARC INC COM STK
IAR
$0 ﹤0.01%
+147
New
WRSP
2428
DELISTED
WORLDSPACE, INC.
WRSP
$0 ﹤0.01%
+35
New
KPN
2429
DELISTED
ROYAL KPN NV ADS (EA REPTG 1 ORD SH)
KPN
$0 ﹤0.01%
189
-19,877
-99%
INPC
2430
DELISTED
INPHONIC INC
INPC
$0 ﹤0.01%
+217
New
TKP
2431
DELISTED
TECHNIP ADS (EA REPTG ONE ORD SHS)
TKP
-490,264
Closed -$8.77M
PGS
2432
DELISTED
PETROLEUM GE0-SVCS ASA SPON ADR NEW
PGS
$0 ﹤0.01%
135
PDLI
2433
DELISTED
PDL BioPharma, Inc.
PDLI
$0 ﹤0.01%
393
UBA
2434
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
-500
Closed -$12K
CMO
2435
DELISTED
Capstead Mortgage Corp.
CMO
$0 ﹤0.01%
118
CCIH
2436
DELISTED
Chinacache International Holdings Ltd
CCIH
$0 ﹤0.01%
67
AST
2437
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$0 ﹤0.01%
4
CGG
2438
DELISTED
CGG
CGG
$0 ﹤0.01%
4
WR
2439
DELISTED
Westar Energy Inc
WR
-934
Closed -$52K
RTK
2440
DELISTED
Rentech, Inc.
RTK
$0 ﹤0.01%
100
BCS.PRA.CL
2441
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
-1,000
Closed -$25K
RJD.CL
2442
DELISTED
Raymond James Financial Inc
RJD.CL
-600
Closed -$15K
INZ.CL
2443
DELISTED
Ing Groep N.v.
INZ.CL
-3,230
Closed -$82K
QUNR
2444
DELISTED
Qunar Cayman Islands Limited
QUNR
-20
Closed
REG.PRF.CL
2445
DELISTED
Regency Centers Corporation
REG.PRF.CL
-600
Closed -$15K
VNR
2446
DELISTED
Vanguard Natural Resources, LLC
VNR
$0 ﹤0.01%
3,031
ICA
2447
DELISTED
EMPRESAS ICA, S.A. DE C.V. ADS (EA REPTG 4 ORD PART CERT)
ICA
$0 ﹤0.01%
519
UTA
2448
DELISTED
Universal Travel Group New Common Stock
UTA
$0 ﹤0.01%
+2,500
New
QGENF
2449
DELISTED
QIAGEN NV
QGENF
-31,953
Closed -$894K
GCVRZ
2450
DELISTED
Sanofi Contingent Value Rights
GCVRZ
-100
Closed

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.